J Shafiq
Overview
Explore the profile of J Shafiq including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
241
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Powell A, Batumalai V, Wong K, Kaadan N, Shafiq J, Delaney G, et al.
Clin Oncol (R Coll Radiol)
. 2024 Aug;
36(10):651-657.
PMID: 39117508
Purpose: Radiotherapy (RT) is an integral component in the treatment of breast cancer. The aims of this study were to estimate the cost per 5-year Local Control (LC) and Overall...
2.
Batumalai V, Descallar J, Delaney G, Gabriel G, Wong K, Shafiq J, et al.
Radiother Oncol
. 2020 Dec;
156:174-180.
PMID: 33359268
Background And Purpose: There is a paucity of studies examining variation in the use of palliative radiation therapy (RT) fractionation for brain metastases. The aim of this study is to...
3.
Batumalai V, Descallar J, Delaney G, Gabriel G, Wong K, Shafiq J, et al.
Radiother Oncol
. 2020 Nov;
154:299-305.
PMID: 33217497
Background And Purpose: Adoption of single-fraction radiation therapy (SFRT) has not been universal in the palliative treatment of bone metastases, despite evidence supporting its safety and efficacy. The aim of...
4.
Hanna T, Shafiq J, Delaney G, Vinod S, Thompson S, Barton M
Radiother Oncol
. 2017 Dec;
126(2):191-197.
PMID: 29229506
Background: To describe the population benefit of radiotherapy in a high-income setting if evidence-based guidelines were routinely followed. Methods: Australian decision tree models were utilized. Radiotherapy alone (RT) benefit was...
5.
Yap M, Hanna T, Shafiq J, Ferlay J, Bray F, Delaney G, et al.
Clin Oncol (R Coll Radiol)
. 2016 Dec;
29(2):72-83.
PMID: 27916340
More than half of all cancer diagnoses worldwide occur in low- and middle-income countries (LMICs) and the incidence is projected to rise substantially within the next 20 years. Radiotherapy is...
6.
Shafiq J, Hanna T, Vinod S, Delaney G, Barton M
Clin Oncol (R Coll Radiol)
. 2016 Jun;
28(10):627-38.
PMID: 27260488
Aims: To estimate the population-based locoregional control and overall survival benefits of radiotherapy for lung cancer if the whole population were treated according to evidence-based guidelines. These estimates were based...
7.
Hanna T, Shafiq J, Delaney G, Barton M
Radiother Oncol
. 2015 Mar;
114(3):389-94.
PMID: 25733007
Purpose: Population benefits of radiotherapy if evidence-based guidelines were routinely followed across the entire population are largely unknown. The aim of this study was to investigate population-based benefits for cervical...
8.
Hanna T, Shafiq J
Clin Oncol (R Coll Radiol)
. 2014 Dec;
27(2):99-106.
PMID: 25466333
The measurement of population benefits is important for priority setting, economic evaluation and quality improvement. It also informs advocacy. In this article, the use of demand models to estimate the...
9.
Fong A, Shafiq J, Saunders C, Thompson A, Tyldesley S, Olivotto I, et al.
Breast
. 2012 Mar;
21(4):570-7.
PMID: 22425535
Background: Different jurisdictions report different breast cancer treatment rates. Evidence-based utilization models may be specific to derived populations. We compared predicted optimal with actual radiotherapy utilization in British Columbia, Canada;...
10.
Kumar S, Juresic E, Barton M, Shafiq J
J Med Imaging Radiat Oncol
. 2010 Jul;
54(3):264-79.
PMID: 20598015
Acute skin toxicity occurs in the majority of the patients undergoing radical radiotherapy. While a variety of topical agents and dressing are used to ameliorate side effects, there is minimal...